Mergers & Acquisitions Mergers & Acquisitions

Boston Scientific, MI Tech abandon proposed transaction due to regulatory hurdles

By Flavia Fortes
  • 24 May 2023 18:38
  • 24 May 2023 18:38
Boston Scientific and South Korean non-vascular stent manufacturer MI Tech have abandoned their proposed transaction in light of regulatory hurdles in the US and abroad.
The US Federal Trade Commission today said the companies called the deal off in response to investigations by the commission and from foreign enforcement agencies.

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Flavia Fortes

Global Head of Mergers

Flavia writes about merger control, antitrust enforcement and litigation in the U.S. and Brazil. Before joining MLex, Flavia worked as an Antitrust Consultant in the Federal Trade Commission's Office of International Affairs and as a Research Fellow for the American Antitrust Institute. She has written on the intersection of antitrust law and intellectual property law in technology-driven and innovative markets.

Discover MLex

Stay on top of global regulatory developments

Latest News